Mkts

Gyre Therapeutics, Inc.

NASDAQ: GYRE
$4.26+0.03 (+0.71%)
As of Nov 11, 4:00 PM ET

Key statistics

Day range
4.224.38
52-week range
3.979.14
Today
Open4.26
Previous close4.26
Volume—
Valuation
Market cap497.03M
P/E ratio—
EPS (TTM)-0.18
Income & risk
Dividend / yield—
Beta2.64
Avg volume124.8K
Discussion

GYRE News

Stories mentioning GYRE from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue22,51937,19530,56426,77122,05827,87225,48825,225
Cost of Goods Sold1,2271,7431,6281,151894.001,177958.00770.00
Gross Profit21,29235,45228,93625,62021,16426,69524,53024,455
Operating Expenses
Research & Development6,7384,8152,3633,4253,0953,7122,7753,355
Sales General & Admin
Total Operating Expenses31,87439,85622,01123,44919,78529,91420,29721,261
Operating Income (Loss)(9,355)118.006,9252,1712,273665.004,2333,194
Interest Income
Interest Expense
Other Expense29.00(2,194)727.00(145.00)107.00(1,634)(75.00)(72.00)
Pretax Income(9,237)(66.00)7,6292,2384,635772.003,9306,035
Tax Provision621.001,3001,693662.00901.00203.001,0741,497
Net Income (Loss)(9,858)(1,366)5,9361,5763,734569.002,8564,538
Earnings Per Share (Basic)(0.10)(0.02)0.040.000.030.010.010.04
Earnings Per Share (Diluted)(0.10)(0.01)0.030.000.000.010.010.01
Weighted Average Shares Outstanding (Basic)91,31789,34590,85089,11986,42185,09585,64485,502
Weighted Average Shares Outstanding (Diluted)91,345103,180103,972102,702101,971102,294102,640102,206

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About GYRE

Gyre Therapeutics, Inc. (NASDAQ: GYRE) is a stock listed on the Nasdaq Stock Market under the ticker symbol GYRE. It last traded at $4.26 (Nov 11, 2026, 4:00 PM ET), up 0.7% on the day. That gives Gyre Therapeutics a market capitalisation of $497.0M.

Over the past 52 weeks GYRE has traded between $3.97 and $9.14.

Revenue for the quarter ended Mar 31, 2026 was $22.5M; a net loss of $9.9M. Revenue was up 2.1% from $22.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$22.5M-$9.9M-43.8%
Dec 31, 2025$37.2M-$1.4M-3.7%
Sep 30, 2025$30.6M$5.9M19.4%
Jun 30, 2025$26.8M$1.6M5.9%

From Gyre Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…